|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.28 USD | -6.26% |
|
-24.32% | -36.29% |
Kazia Therapeutics Limited reported earnings results for the full year ended June 30, 2023. For the full year, the company reported net loss was AUD 20.47 million compared to AUD 25.01 million a year ago. Basic loss per share from continuing operations was AUD 1.123 compared to AUD 1.888 a year ago.
Diluted loss per share from continuing operations was AUD 1.123 compared to AUD 1.888 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -36.97% | 7.87M | |
| +20.70% | 42.68B | |
| -2.99% | 42.4B | |
| +45.32% | 40.04B | |
| -6.20% | 28.31B | |
| +7.85% | 24.94B | |
| -19.68% | 18.96B | |
| +30.30% | 12.3B | |
| -2.70% | 11.95B | |
| -2.98% | 11.55B |
KAZIA THERAPEUTICS LIMITED 
